Effectiveness of review process in eye of beholder

California legislators passed the Friedman-Knowles Act of 1998 to, according to the California HealthCare Foundation, require HMOs to "provide external and independent medical review for specific classes of patients who requested investigational or experimental treatments that were denied by their health plan."

From January 1999 to December 2000, 263 independent medical reviews were conducted in California as a result of patients trying to overturn coverage decisions by health plans. The Institute of Medical Quality, on behalf of the foundation, surveyed those patients to obtain their opinions regarding the effectiveness of the review process.

Perhaps not surprisingly, patients' views of the process differed according to whether their requests had been approved or denied.

To what extent has the independent medical review process increased people's trust in their health plans?

How confident are you that the patient's specific medical issues were considered?

How confident are you that the medical experts conducted a fair and impartial review?

How confident are you that the medical experts thoroughly considered available scientific information?


Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.


Managed Care
By Peter Wehrwein
Managed Care
By Howard Wolinsky